{"id":12135,"date":"2025-03-13T21:00:25","date_gmt":"2025-03-13T20:00:25","guid":{"rendered":"https:\/\/valintermed.com\/?p=12135"},"modified":"2025-03-13T21:00:25","modified_gmt":"2025-03-13T20:00:25","slug":"myullerova-aplaziya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/myullerian-aplasia\/","title":{"rendered":"M\u00fcllerian aplasia"},"content":{"rendered":"
<\/div>\n

M\u00fcllerian aplasia, also known as M\u00fcller syndrome, is a congenital disorder that belongs to a group of abnormalities in the development of the female genital organs. This disorder is associated with the absence or underdevelopment of the uterus and the upper third of the vagina, which causes a number of clinical manifestations, including primary amenorrhea. The pathology occurs as a result of abnormalities in embryogenesis, which lead to abnormalities in the formation of the M\u00fcllerian ducts, which are responsible for the development of female genital structures. Despite the presence of normal ovaries, women with M\u00fcllerian aplasia may experience difficulties with fertility and the menstrual cycle, which requires a comprehensive approach to the diagnosis and treatment of this condition.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n